Hi @[Miray Tayfun](user:130396), I love the premise behind Vivoo, in striving to achieve personalized healthcare, with the help of technology and sensitivity to cost-effectiveness. I could be wrong, but but my assumption is that urine and sweat are quite similar in chemical breakdown, with different levels of concentration and a few different components. If it is okay to ask, why did Vivoo decide to use urine as the model, instead of sweat?

Hi Norman, thank you for this article. As part of understanding V, it makes sense as to the slower turnover right now due to this pandemic, but why do you personally think we have seen such "a rapid fall in velocity" pre-COVID 19?

Hi Dr. Duru, do you see $TWTR on the rise the next few months, throughout the election process- as comparatively to other multimedia/ social media/ news companies?

And how do you see that playing out into June and the rest of this pandemic?

Thank you Karl, I plan on reading both of those articles and look forward to possibly discussing them too.

Regarding your response, do you see healthcare/biotech companies that are not intrinsically related to the benefits of this new environment facing tougher challenges with regard to raising funds? And if they do face challenges, do you think that you could equate the challenge of raising money for companies in this sector (healthcare/biotech) to companies in other sectors?

Hi Gene, first of all, thank you for your article. As you mentioned in your executive summary, there as so many moving parts to the current market climate. Specifically, you mentioned that the S&P has continued to rise, as you also mentioned the belief for therapeutic drug soon. Obviously, there are so many factors at play with the "emotions" of the overall market and the S&P, but how do you see the possible effect of the therapeutic drug search not going as fast as some believe it to be?

Exactly, therefore, Adam and Danny, do you both imagine that the market opportunity for antibody testing will be smaller than many perceive it to be? Or do you think that the mass public will according to this reasoning, blindly take the tests anyway?

Being that there is no clear evidence that having antibodies offers complete protection from this virus, do you imagine that the market opportunity for antibody testing will be smaller than many perceive it to be?

Nick, with the predicted amount of uncertainty as to which exact pharma will be successful in finding a vaccine, do you imagine that these stocks will start to rise soon, even though it has been slumping since mid-April?

Hi Lorimer, do you imagine that one of the reasons that we have seen such a significant advancement in the cannabis stock sector these past two months is correlated to the fact that many people were stuck at home, either without a job or a more lax job?